Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers
Authors:
- 1 April 2019
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 55, 8-15
Abstract
No abstract availableKeywords
Funding Information
- Drs. Ji and Li Family Cancer Research Foundation
- National Cancer Institute, the Clinical Proteomic Tumor Analysis Consortium (U24CA210985)
This publication has 69 references indexed in Scilit:
- Integrated molecular analysis of clear-cell renal cell carcinomaNature Genetics, 2013
- Imaging the Clear Cell Renal Cell Carcinoma ProteomeJournal of Urology, 2013
- Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeuticsGenome Research, 2012
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion SequencingNew England Journal of Medicine, 2012
- KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinomaJournal of Human Genetics, 2011
- Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinomaNature, 2011
- Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell CarcinomaPLOS ONE, 2010
- The genetic basis of kidney cancer: a metabolic diseaseNature Reviews Urology, 2010
- Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery EquationClinical Chemistry, 2010
- Sorafenib in Advanced Clear-Cell Renal-Cell CarcinomaNew England Journal of Medicine, 2007